Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
Sorbonne Université · Assistance Publique – Hôpitaux de Paris · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
622
total citations
- FWCI
- 36.10
- Percentile
- 100%
- References
- 50
Citations per year
Authors
12- VRVlad RatziuCorresponding
Sorbonne Université, Assistance Publique – Hôpitaux de Paris
- PGPhilippe Giral
Inserm, Centre de Recherche Saint-Antoine
- SJSophie Jacqueminet
Sorbonne Université, Assistance Publique – Hôpitaux de Paris
- FCFrédéric Charlotte
Sorbonne Université, Assistance Publique – Hôpitaux de Paris
- AHAgnès Hartemann–Heurtier
Sorbonne Université, Assistance Publique – Hôpitaux de Paris
Topics & keywords
Topics
Keywords
- Rosiglitazone
- Nonalcoholic steatohepatitis
- Medicine
- Placebo
- Randomized controlled trial
- Internal medicine
- Fatty liver
- Steatohepatitis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.